To Lie, Cheat, and Steal!
GSK’s settlement will be the largest to date among federal cases against pharmaceutical companies accused of off-label marketing (research and marketing for things the drug is not designed to do), eclipsing the previous record of $2.3 billion paid by Pfizer in 2009 (see above link). GSK's previous record fine was $1 billion for birth defects caused by its ANTI-DEPRESSION MEDICATION PAXIL. However, in October 2010, it set another record, paying a fine of $150 million, the largest ever to settle criminal charges for knowingly marketing products produced at a contaminated facility (Puerto Rico), including Paxil, Avandia (which increases risk of heart failure by 60 percent, heart attack by 40 percent, and death in patients age 65 and over by 30 percent), Bactroban -- an ANTIBIOTIC OINTMENT; Coreg -- a heart drug; and Tagamet -- an ACID REFLUX drug. Hey; it's OK ---- they said they were sorry.